Document Detail

Salvage transoral laser microsurgery for early recurrent glottic carcinoma after primary laser treatment.
MedLine Citation:
PMID:  23350599     Owner:  NLM     Status:  Publisher    
Abstract Conclusion: Salvage transoral laser microsurgery (TLM) may be a curative organ-preserving treatment for early recurrent glottic carcinoma after primary laser resection. However, failure after TLM seems to be associated with decrease of survival and larynx preservation rates. Objective: To evaluate the oncological results of salvage TLM for early recurrent glottic carcinoma after primary laser treatment. Methods: Records of 50 patients with local recurrences of glottic carcinoma treated by salvage TLM between January 1994 and December 2008 were retrospectively analyzed. Results: Thirty-six rT1 and 14 rT2 lesions were treated with salvage TLM. Mean follow-up was 68.3 months. Thirty-one patients were cured by first salvage TLM and four by further laser procedures. The other 15 patients were finally salvaged by laryngectomy or radiotherapy. Five-year overall survival, disease-specific survival, local control, and loco-regional control rates were 89.9%, 97.9%, 62.3%, and 60.1%, respectively. Larynx preservation rate after long-term follow-up was 86%. In univariate analysis, second local recurrence showed a statistically significant impact on disease-specific survival rate ( p = 0.049) and larynx preservation rate ( p = 0.006). In multivariate analysis, it was associated with a statistically significant decrease in larynx preservation rate ( p = 0.016). There was no statistically significant difference in oncological results between patients with and without anterior commissure involvement.
Junwei Huang; Zhenkun Yu; Jugao Fang; Xiaohong Chen; Xuejun Chen; Zhigang Huang
Related Documents :
16145389 - Validation of criteria used to predict extraprostatic cancer extension: a tool for use ...
22172569 - A multi-institutional phase ii trial of consolidation s-1 after concurrent chemoradioth...
18359669 - Equivalent uniform dose, d(90), and v(100) correlation with biochemical control after l...
22002799 - Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neopl...
2529629 - Lhrh analogue as a depot preparation (zoladex) in the treatment of advanced carcinoma o...
24411629 - Bladder function preservation with brachytherapy, external beam radiation therapy, and ...
17522879 - Clear cell chondrosarcoma of bone: long time follow-up of 18 cases.
7508679 - Immunomodulation in the treatment of malignant disorders.
2288719 - Rationales for combining chemotherapy and biotherapy in the treatment of cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-28
Journal Detail:
Title:  Acta oto-laryngologica     Volume:  -     ISSN:  1651-2251     ISO Abbreviation:  Acta Otolaryngol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370354     Medline TA:  Acta Otolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University), Ministry of Education , Beijing , China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment outcomes of closed reduction of arytenoid dislocation.
Next Document:  Cervical lymph node metastasis from early-stage squamous cell carcinoma of the oral tongue.